Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems has inaugurated two new expansions at its Mississauga location to enhance its medical devices manufacturing capabilities, witnessed by Ontario’s Associate Minister of Small Business, the Honourable Nina Tangri. The first addition is a 2,000 square foot lab for quality assessment products and internal QC, marking a 13% capacity increase. The second is a new automated vial-filling line for in-vitro diagnostics, bolstered by government grants and loans supporting the company’s growth in producing innovative diagnostic tests.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
